# MEXILETINE HYDROCHLORIDE
> **ANDA213500** · Abbreviated New Drug Application (Generic) · Sponsor: CROSSMEDIKA SA · Approved 2020-07-22
## Drug
- **FDA Application Number:** ANDA213500
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEXILETINE HYDROCHLORIDE
- **Generic name:** MEXILETINE HYDROCHLORIDE
- **Active ingredients:** MEXILETINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CROSSMEDIKA SA
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2020-07-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213500)
---
*AI Analytics · CC0 1.0*